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A B S T R A C T
Objectives: Acute rheumatic fever (ARF) is a major cause of morbidity and mortality in developing
nations. The objective of this study was to determine the disease burden of ARF among the indigenous
and non-indigenous populations of the Northern Mariana Islands.
Methods: This was a chart review of all pediatric outpatients seen from 1984 to 2006 with ICD-9 codes
corresponding to rheumatic fever or any rheumatic cardiac sequelae. The study was set in the only
comprehensive inpatient facility and only public pediatric clinic in the Northern Mariana Islands.
Results: Onehundredﬁfty-eight casesofARFwere identiﬁed.Ageatdiagnosis rangedfrom2.9 to17.1years
(median10.6years). Feverandcarditiswere themost commonpresentingﬁndings.Theaverageannualized
incidence of ARFwas85.8 per 100 000person-years for those aged5–14years. Sixty-sixpercent of patients
with ARF were of Chamorro or Carolinian ancestry, despite comprising only 39% of the total population,
with a combined average annualized incidence of ARF of 167 per 100 000 person-years.
Conclusions: This is the ﬁrst documentation of the incidence of pediatric ARF in the Northern Mariana
Islands, delineating the large disease burden in the indigenous and other Paciﬁc Island ethnic groups.
Impediments to diagnosis and primary and secondary prevention were identiﬁed. The data provide
strong support for the need for primary and secondary prevention of ARF.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Rheumatic heart disease (RHD) is a major cause of morbidity
and mortality in the developing world. It is estimated that over 15
million people have RHD worldwide, with 282 000 new cases and
233 000 deaths annually.1 Numerous reports have shown an
increased incidence in people of various ethnic backgrounds,
including Paciﬁc Islanders and Australian aboriginals.2,3 Samoans
living in Samoa and Hawaii, have an estimated prevalence of RHD
of 77.8 per 1000 and an incidence of acute rheumatic fever (ARF) of
206 per 100 000, respectively.2,3 It is unclear why these
populations have an increased incidence of ARF, but it is thought
to result from a combination of host factors, streptococcal strains,
environment, and nutrition. We sought to study the incidence of
ARF in the Northern Mariana Islands among the indigenous
Chamorros and Carolinians and the non-indigenous populations.
2. Materials and methods
The Northern Mariana Islands, a Commonwealth of the USA,
are a chain of 15 islands in the Western Paciﬁc that start 50 miles* Corresponding author. Tel.: +1 434 924 9119; fax: +1 434 924 5656.
E-mail address: seckeler@hotmail.com (M.D. Seckeler).
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doi:10.1016/j.ijid.2009.04.003north of Guam and extend over 400 miles further north. The
population of nearly 70 000 is comprised of a mix of Paciﬁc Island
groups as well as Chinese, Filipino, Japanese, Korean, Nepalese,
Bangladeshi, White Americans, and African Americans and is
divided among three islands: Saipan, the capital, with 90% of the
population and Tinian and Rotawith 5% each. The Commonwealth
Health Center (CHC), located on Saipan, is the sole provider of
comprehensive inpatient healthcare services in the Northern
Mariana Islands, the referral center for the other Mariana Islands,
and houses the only public pediatric clinic providing care for the
indigent population. The CHC provides care to 75% of the pediatric
population and 100% of the uninsured population in the Northern
Mariana Islands. There are clinics located on Tinian and Rota, but
all complicated pediatric cases, such as ARF, are referred to Saipan
for further care. The nearest tertiary care centers are 1500miles to
thewest in Japan and the Philippines and 3700miles to the east in
Hawaii. The CHC is able to provide primary care and surgical
services as well as diagnostic studies such as echocardiography,
but patients who require complex surgical procedures and
advanced cardiac imaging must be sent to off-island centers for
their care.
We performed a retrospective chart review of ARF presenta-
tions from 1984 to 2006. Computer-based records were searched
for CHC outpatient pediatric visits with an ICD-9 code correspond-
ing to ARF or any rheumatic cardiac sequelae (390.0–398.99)ses. Published by Elsevier Ltd. All rights reserved.
Table 1
Presenting ﬁndings of acute rheumatic fever in all patients
Finding n %
Fever 126 80.8
Antibody titer positive 115 72.7
Carditis 86 54.4
Arthritis 80 51.0
Arthralgia 49 31.2
Throat culture positive 27 31.0
Rash 9 5.7
Chorea 8 5.1
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November 30, 2006. This initial query returned 223 patients,
with encounters in the paper charts dating back to 1984.
Records were excluded from analysis if the patient was aged over
21 years before 1992 and if a diagnosis of ARF could not be
corroborated in the chart (including cases where the chart could
not be located).
The data collected from the medical records included date of
birth, date of diagnosis, age at diagnosis, sex, ethnicity, presenting
Jones criteria, cardiac involvement at diagnosis, and any recur-
rences of ARF. Diagnostic criteria for ARF included any illness
meeting the Jones criteria.4 Cases that did not fully satisfy the Jones
criteria had often been classiﬁed as ARF given the problem of
underdiagnosis. Carditis was deﬁned as either a new murmur on
physical examination and/or valvular thickening noted on
echocardiogram, when available. A streptozyme titer of at least
1:100, an antistreptolysin O titer greater than 150 Todd units, or a
throat culture positive for group A Streptococcus was considered
evidence of streptococcal infection. In accordance with World
Health Organization guidelines, a recurrence of ARFwas diagnosed
in a patient with prior ARFwho had a subsequent episode of illness
that either met strict Jones criteria4 or had several minor criteria
with evidence of streptococcal infection.5 Prior ARF is considered a
major criterion.5
Incidence data were calculated using census data from 1980,
1990, 1995, and 2000.6 The denominator was all children aged 5–
14 years to be comparable with ﬁndings from other studies; a
constant population was used for each date range (i.e., 6176
children for all calculations from 1990 through 1994). Cases
diagnosed at ages outside of this range were excluded from the
incidence calculation. The annual average number of cases of ARF
diagnosed over each time period (1984–1989, 1990–1994, 1995–
1999, and 2000–2006) constituted the numerator.
There were no data available speciﬁcally enumerating the 5–
14-year-olds for each ethnic group in order to calculate ethnicity-
speciﬁc incidences of ARF. Therefore, we estimated the incidence
for each ethnic group based on their percentage of the total
population and calculating aweighted average population of 5–14-
year-olds over the study period for each group. This number
constituted the denominator. For example, Chamorros constitute
56.7%, 29%, 23.5%, and 21.3% of the total population for 1984–1989,
1990–1994, 1995–1999, and 2000–2006, respectively, giving a
weighted average of 2067.7 Chamorros aged 5–14 years for the
entire study period. For the numerator, we used the annual average
number of cases over 23 years for each ethnic group. So, for
Chamorros, therewere a total of 62 cases of ARF in those aged 5–14
years, giving an annual average of 2.7 cases over 23 years. There
were insufﬁcient census data to perform this calculation for the
one case of ARF among native Hawaiians during the study period.
Statistical calculations were performed with OpenEpi version
2.2.1.7
3. Results
One hundred ﬁfty-eight new, unique cases of ARF were found
through the chart review. Recurrent cases of ARF were not countedTable 2
Incidence per 100 000 person-years and incidence rate ratios of acute rheumatic feve
conﬁdence intervals in parentheses
1984–1989 1990–1994
Number ARF (annual mean) 1.2 5.4
Population 5–14 years 4339 6176
Incidence ARF 5–14 years 26.9 (11.8, 53.2) 87.4 (58.8,
Incidence rate ratio (reference 2000–2006) 0.22 (0.09, 0.45) 0.71 (0.45in this total. Age at diagnosis ranged from 2.9 to 17.1 years, median
10.6 years; 102 patients (64.6%) were male.
A list of presenting ﬁndings is shown in Table 1. Fever was the
most prevalent ﬁnding, followed by carditis. Throat culture was
positive in 31% of patients, but was only obtained in 55% of
patients. Seventy-two percent of patients had positive serology as
deﬁned in theMethods section, but only 79% of patients had either
an antistreptolysin O titer or streptozyme checked and documen-
ted. Antistreptolysin O titers ranged from 47 to 3791 Todd units;
streptozyme titers ranged from 1:100 to 1:800. Ten patients (8%)
had antistreptolysin O titers less than 150 Todd units. No patients
presented with subcutaneous nodules. Strict Jones criteria4 were
met in 118 (74.7%) patients. Recurrences were documented in 61
(38.6%) patients.
Table 2 shows the average annualized incidence of ARF for all
those aged 5–14 years during the periods 1984–1989, 1990–1994,
1995–1999, and 2000–2006. The average annualized incidence of
ARF for the entire study period was 85.8 cases per 100 000 person-
years. Four children aged younger than 5 years and 11 aged older
than 14 years were excluded from the incidence calculations.
Incidence rate ratios comparing each time period are shown in
Table 2.We extrapolated ARF incidence for each ethnic group using
the census data as explained in the Methods section, with results
shown in Table 3.
Ninety-ﬁve (66.4%) patients diagnosed with ARF were of
Chamorro or Carolinian ancestry, who comprised an average of
39.3% of the population during the study period (Table 3). One
hundred thirty-four (93.7%) of the ARF patientswere of any Paciﬁc
ancestry, althoughPaciﬁc Islanders comprised an average of 47.1%
of the total population over the study period. The combined
average annualized incidence for the indigenous Chamorro and
Carolinian groups was 167 cases per 100 000 person-years (95%
conﬁdence interval 135.8–203.2); incidence rate ratios compar-
ing them to the other ethnic groups are shown in Table 3. There
were no cases of ARF among the Chinese, Japanese, Korean,
Nepalese, Bangladeshi, or African American ethnic groups, who
comprised an average of 25.1% of the population during the study
period.
Comparing the percentage of patients with evidence of carditis
at diagnosis before and after the acquisition of Doppler echocar-
diographic equipment produced a z-score of 1.57.
Data were not available regarding most patients’ use of non-
steroidal anti-inﬂammatory drugs (NSAIDs) prior to ARF diagnosis.r (ARF) among those aged 5–14 years in the Northern Mariana Islands with 95%
1995–1999 2000–2006 1984–2006
4.8 12.1 6.2
8219 9797 7243
125.5) 58.4 (38.3, 85.6) 123.9 (99.6, 152.5) 85.8 (72.6, 100.8)
, 1.08) 0.47 (0.29, 0.73) - -
Table 3
Number of cases of acute rheumatic fever (ARF) and incidence per 100 000 person-years for those aged 5–14 years for the 23-year study period (1984–2006) among the
different ethnic groups in the Northern Mariana Islands and population breakdown for the Northern Mariana Islands
Ethnicity n % of ARF % of population Incidence of ARF Incidence rate ratio
(reference indigenous population)b
Chamorroa 62 43.4 32.6 130.4 (100.8, 166) -
Caroliniana 33 23.1 6.7 353.2 (247.2, 490.3) -
Palauan 16 11.2 3.5 300.5 (177.9, 477.6) 1.8 (1.03, 3)
Chuukese 12 8.4 2.0 354.9 (192.3, 603.3) 2.13 (1.12, 3.77)
Filipino 8 5.6 25.5 18 (8.3, 34.1) 0.11 (0.05, 0.21)
Ponapean 5 3.5 1.1 281.3 (103.1, 623.5) 1.69 (0.61, 3.85)
Yapese 3 2.1 0.4 497.8 (126.6, 1355) 2.98 (0.75, 8.33)
Marshallese 2 1.4 0.4 418.5 (70.2, 1383) 2.51 (0.41, 8.47)
White American 1 0.7 1.7 31.2 (1.6, 153.8) 0.19 (0.01, 0.94)
Hawaiian 1 0.7 - - -
Other 0 0 25.1 0 0
a Indigenous population.
b Incidence rate ratios comparing combined indigenous Chamorro and Carolinian groups (167 per 100 000 person-years) to other ethnicities.
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In developing countries ARF and RHD are the leading causes of
cardiovascular mortality during the ﬁrst 50 years of life. Improved
living standards are believed to account for the reduced rate of ARF
in industrialized nations. Antimicrobial therapy of streptococcal
pharyngitis and shifting serotypes have undoubtedly also con-
tributed to the marked decrease in disease incidence. However, an
unexplained, albeit geographically limited resurgence of ARF was
recorded in the USA during the last two decades of the twentieth
century.8,9
This investigation has produced the ﬁrst incidence data of ARF
for children in the Northern Mariana Islands. The average
annualized incidence of ARF among all ethnic groups of 85.8 per
100 000 person-years for patients aged 5–14 years is comparable
to other high incidence populations such as the New ZealandMaori
and Paciﬁc Islander populations.10
The indigenous populations of Chamorros and Carolinians
constitute only 39.3% of the total population of the Northern
Mariana Islands and have a combined average annualized
incidence of 167 cases per 100 000 person-years. It appears that
all Paciﬁc Islander groups have a markedly higher incidence of ARF
as compared to non-Paciﬁc Island ethnic groups (Table 3). The
reason for this increased incidence is unclear, but is consistentwith
previous ﬁndings among Samoans living in Hawaii.3While some of
the represented ethnic groups had a small population during the
study period, these ﬁndings are still quite provocative, and are an
excellent area for further study.
In retrospect, the decision to exclude patient records that did
not have the encounter for ARF diagnosis may have been too strict.
As a consequence, our ﬁndings are biased to a lower incidence. It
was not possible to calculate prevalence data for RHD as the record
review included only outpatient visits for pediatric patients. While
many patients are treated without a hospital admission for their
ARF, those who were hospitalized during their initial attack of
rheumatic fever and did not return to CHC for follow-up care were
not identiﬁed. There are also patients with ARF who are treated in
the private physician clinics; such patients may not have been
identiﬁed through this chart review if they were receiving oral
antibiotic secondary prophylaxis. Clearly this is a limitation of the
study that leads to an underestimate of the incidence of ARF in the
Northern Mariana Islands; a review of inpatient records would
have provided more data. Those adults who were diagnosed prior
to our study time period and are still living are another group not
identiﬁed in the database query.
Only 75% of the patients in this review met strict Jones criteria
based on the 1992 consensus report, however all had been
diagnosed with ARF and referred for secondary antibioticprophylaxis given the high incidence of disease in the community.
Of the 25% of patients with incomplete diagnoses, most were
diagnosed by multiple minor Jones criteria with evidence of
streptococcal infection. Some charts, however, did not include
throat culture or serology results, and these were considered
incomplete diagnoses. Ralph et al. proposed an expansion of the
diagnostic criteria in high incidence areas, and suggested the
inclusion of ‘probable’ and ‘possible’ ARF to identify patients who
may require secondary antibiotic prophylaxis and closer follow-
up,11 which is how this patient subset should have been treated. In
addition, consideration should be given to the inclusion of
monoarthritis as a major criterion in areas of high incidence.12,13
It has been noted, however, that patients who present with
monoarthritis may have been previously exposed to disease-
altering NSAIDs before the diagnosis of ARF.14 NSAID use prior to
presentation could not be reliably extracted from the medical
records in this study.
An antistreptolysin O titer of greater than 150 Todd units was
considered evidence of prior streptococcal infection, although it
has been suggested that in areas with higher background rates of
streptococcal infections a higher cut-off should be used, even as
high as 320 Todd units.15 Using a cut-off of 320 Todd units, 29
patients would be eliminated from the data set because of no
additional evidence of streptococcal infection. While there is
certainly controversy regarding the reliability of the streptozyme
assay, limited resources and availability of tests were considered
when evaluating the data.
There has been an apparent increase in the annual incidence of
ARF over time in the NorthernMariana Islands pediatric population
(Table 2). Only seven caseswere identiﬁed from1984 through 1989,
however fewchartswere reviewed fromthis timeperiod, increasing
the likelihood that additional diagnoses were missed. The data in
Table 2 show a statistically signiﬁcant increase in ARF incidence
when comparing 2000–2006 to the three prior time periods. It is
unclear at this time if the increase can be attributed to a true change
in the number of cases, an increased awareness of ARF among
patients and care providers, or improved detection after the
acquisition of Doppler echocardiography equipment in 1999. Before
1999, 47% of patients presentedwith carditis and after 1999, 60% of
patients presented with carditis. However, this only trended
towards statistical signiﬁcance and can be attributed to many
factors other than the quality of echocardiography equipment.
When available in the chart, only echocardiographic ﬁndings from
the initial diagnostic evaluation were noted.
A recurrence rate of nearly 40% among our population is
exceedingly high, despite a nurse-driven secondary prophylaxis
program in both the pediatric and adult clinics at CHC. Also of note,
was the high rate (31%) of positive group A streptococcal throat
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are lost to follow-up during the transition from pediatric to adult
care, which occurs at 16 years of age in our facility. No centralized
register of patients with ARF and RHD in the Northern Mariana
Islands exists, although it is anticipated that the data reported here
will facilitate its development to improve the administration of
secondary prophylaxis.
The numerous patients found to have valvular thickening on
echocardiogram at initial diagnosis suggests that there are patients
who have prior or recurrent episodes of ARF that are undiagnosed.
The factors that contribute to missed diagnoses are diverse and
include lack of parental awareness of the potential seriousness of a
child’s complaint of pharyngitis and the lack of physician and nurse
practitioner cognizance of the incidence of ARF in the Paciﬁc Island
populations, whichmay result in a less aggressive pursuit of ARF as
a diagnosis.
The results of this study document the extremely high incidence
of ARF in numerous ethnic groups of Paciﬁc Island descent in the
Northern Mariana Islands. Of note, Marijon et al. recently reported
that the routineuseof echocardiography to facilitate thediagnosisof
ARF in Southeast Asian and sub-Saharan children resulted in a ten-
fold higher prevalence of RHD than diagnosed by clinical examina-
tion alone.16 Their data strongly support the assertion that ARF
represents a much larger disease burden than previously thought
and underscore the need for primary prevention of streptococcal
infections and their long-term sequelae. Our data substantiate the
need for increasedandcontinuedcareprovidereducationaboutARF,
its diagnosis and prevention, as well as secondary prophylaxis.
Group A streptococcal vaccine trials have been initiated in North
America. Characterization of the streptococcal isolates from North-
ern Mariana Islands patients with ARF will be vital to assure that
appropriate vaccines are considered for Paciﬁc Islander populations.
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